Oddity Tech Launches Methodiq Platform, Expected to Attract Tens of Millions of Users
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2026
0mins
Source: Fool
- Data-Driven Growth: Oddity Tech has enhanced customer loyalty through its direct-to-consumer platform by leveraging data analytics, resulting in higher repeat purchase rates and increased shareholder value.
- Launch of Methodiq Platform: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing personalized treatment solutions for tens of millions of Americans suffering from skin conditions, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI-powered skin analysis and computer vision technology, catering to diverse user needs and further expanding market share.
- Strategic Investment Outlook: With the launch of Methodiq, Oddity Tech is poised to attract more consumers willing to pay premium prices for beauty products, unlocking substantial growth opportunities and driving future shareholder returns.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like ODD with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on ODD
Wall Street analysts forecast ODD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ODD is 66.63 USD with a low forecast of 49.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 33.470
Low
49.00
Averages
66.63
High
80.00
Current: 33.470
Low
49.00
Averages
66.63
High
80.00
About ODD
Oddity Tech Ltd is an Israel-based company engaged in the beauty and wellness sector on the molecular level. The Company is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The Company is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The Company is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oversold Consumer Staples Stocks Present Investment Opportunities: ODD, ELAB, ZVIA
- Oversold Stock Overview: In the consumer staples sector, ODDITY Tech, PMGC Holdings, and Zevia have relative strength indices (RSI) below 30, at 25.3, 16.2, and 26 respectively, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- ODDITY Tech Rating Adjustment: Keybanc analyst maintained an Overweight rating on ODDITY Tech but lowered the price target from $70 to $50, reflecting market caution regarding its future performance, despite its stock price falling approximately 20% over the past month.
- PMGC Holdings Reverse Split: PMGC Holdings announced a 1-for-4 reverse split and invested in non-controlling shares of Nuclea Energy; however, its stock plummeted 73% over the past month, currently at a 52-week low of $3.54 with an RSI of 16.2.
- Zevia Stock Performance: Telsey Advisory Group analyst maintained an Outperform rating for Zevia with a price target of $6, even as its stock fell 33% over the past month to a 52-week low of $1.66, with an RSI of 26 indicating potential for a rebound.
Continue Reading
Mid-to-Low Cap Consumer Staples Stocks Earn A+ EPS Revision Ratings
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
Continue Reading